Results 271 to 280 of about 188,451 (293)

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

Science, 1986
Y. Ben-Neriah, G. Daley, A. Mes-Masson, O. Witte, D. Baltimore   +4 more
semanticscholar   +1 more source

Chronic Myelogenous Leukemia

Archives of Internal Medicine, 1980
openaire   +1 more source

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Increased cancer burden among pesticide applicators and others due to pesticide exposure

Ca-A Cancer Journal for Clinicians, 2013
Matthew R Bonner
exaly  

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

, 1988
J. Goldman, R. Gale, M. Horowitz, J. Biggs, R. Champlin, E. Gluckman, Ray G. Hoffmann, S. Jacobsen, A. Marmont, P. Mcglave, H. Messner, A. Rimm, C. Rozman, B. Speck, S. Tura, R. Weiner, M. Bortin   +16 more
semanticscholar   +1 more source

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Roy F Chemaly, Nassim Hammoudi   +2 more
exaly  

Vascular Access in Oncology Patients

Ca-A Cancer Journal for Clinicians, 2008
Maurizio A Gallieni, Mauro Pittiruti, Roberto Biffi   +2 more
exaly  

Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors

Ca-A Cancer Journal for Clinicians, 2004
Melissa M Hudson
exaly